Oxalates & Autism: What the Research Shows

Susan Owens and the Autism Oxalate Project

Susan Owens is not a credentialed researcher in the formal sense. She is something rarer: a parent-scientist who followed the data into territory no one funded her to explore. Her work on the Autism Oxalate Project began in the early 2000s when she noticed her own child's symptoms tracked with high-oxalate foods. She started measuring, talking to nephrologists, gastroenterologists, and the handful of researchers willing to engage.

Out of that work came the Trying Low Oxalates community — now tens of thousands strong — and a hypothesis with real biochemical legs. Owens connected:

• Elevated urinary and plasma oxalate in autistic children
• Leaky gut as the gateway for hyperabsorption
• Sulfate depletion damaging brain development
• B6 deficiency raising endogenous oxalate production
• Loss of Oxalobacter formigenes after early antibiotic exposure

None of these alone would explain autism. Together, they describe a metabolic situation that no neurotypical body would sit still under.

The Konstantynowicz Paper: The Receipts

In 2012, Konstantynowicz and colleagues published "A potential pathogenic role of oxalate in autism" in the European Journal of Paediatric Neurology. They measured urinary oxalate in 36 autistic children versus 60 controls. The autistic children had 2.5x higher mean urinary oxalate and 3x higher plasma oxalate. Statistically decisive. Clinically alarming.

The authors concluded that hyperoxaluria — at levels not far below what causes kidney damage in primary hyperoxaluria patients — was a feature of autism that demanded further investigation. The investigation has barely happened. The paper has been cited and forgotten in equal measure.

Subsequent work has shown altered oxalate transporter expression, altered Oxalobacter colonization, and cross-reactive features with mitochondrial dysfunction in autism cohorts. The picture is consistent. The intervention studies are missing because nobody is funding them.

The Gut-Brain Axis on Oxalate

Autistic kids have, on average, more GI dysfunction than neurotypical kids. Constipation, diarrhea, reflux, food sensitivities, and visible gut inflammation are over-represented. A leaky gut barrier — increased intestinal permeability — is documented in multiple autism cohorts.

A leaky gut is an oxalate amplifier. Normally, only 1-2% of dietary oxalate is absorbed because the gut wall is mostly impermeable. In a leaky state, absorption can climb to 10-20% or higher. Combine that with diets heavy in spinach smoothies, almond flour, sweet potato, and dark chocolate (all common in "clean" autism-friendly diets) and the daily oxalate load delivered to the bloodstream can be 50-100x normal.

That oxalate then crosses a similarly leaky blood-brain barrier — itself made more permeable by inflammation — and starts depositing in CNS tissue.

The Sulfate Story: The Most Important Mineral You've Never Heard Of

Sulfate is required for: cerebroside myelination, neurotransmitter sulfation (especially dopamine), heparan sulfate proteoglycans on cell surfaces, mucin in the gut, the mucus layer that defines the gut barrier, and Phase II liver detoxification.

Autistic kids are systematically sulfate depleted. Multiple studies have shown low plasma sulfate, low PST (phenol sulfotransferase) activity, and elevated cysteine that fails to convert to sulfate.

Here is the kicker: oxalate and sulfate share transporters. The SLC26A6 and SLC26A1 transporters move both. When the system is loaded with oxalate, sulfate loses. Sulfate gets dumped while oxalate gets re-reabsorbed. Over time, you build oxalate while you bleed sulfate. The neurological cost is enormous.

This is why Epsom salt baths (magnesium sulfate, absorbed transdermally) show up in nearly every functional autism protocol. They bypass the broken transporters and deliver sulfate where the body cannot hold onto it from food.

B6, P5P, and the Endogenous Oxalate Spigot

Vitamin B6 is a cofactor for the enzyme AGT, which converts glyoxylate to glycine. Without enough B6, glyoxylate defaults to oxalate. Autistic kids commonly run low in active B6 (P5P) because they often have impaired conversion from pyridoxine to P5P due to oxidative stress.

The result is a self-reinforcing loop: oxalate causes oxidative stress, oxidative stress reduces P5P activity, low P5P raises endogenous oxalate, more oxalate, more stress. Breaking the loop requires supplemental P5P (the active form, not pyridoxine) at therapeutic doses, alongside magnesium (another P5P cofactor) and B-complex support.

The Bernard Rimland Autism Research Institute documented clinical responses to high-dose B6/magnesium in autistic children for decades. The mechanism, in retrospect, almost certainly runs through oxalate metabolism — even though that wasn't the framing at the time.

The Missing Bacteria: Oxalobacter formigenes

Most healthy adults harbor Oxalobacter formigenes, a gut bacterium that uses oxalate as its only carbon source. It eats the oxalate before your gut can absorb it. Lose Oxalobacter — typically from early-life antibiotics — and your gut becomes a passive conduit for oxalate.

Autistic children, who often have extensive antibiotic histories (ear infections, prenatal exposures, GI workups), are disproportionately Oxalobacter-negative. That, combined with leaky gut and oxalate-heavy food, completes the metabolic perfect storm.

Direct Oxalobacter probiotics are not yet commercially available at consumer scale. The workaround is Lactobacillus and Bifidobacterium strains shown to have some oxalate-degrading capacity (L. acidophilus, B. lactis, certain L. plantarum strains), combined with restoring gut barrier function so any colonizers have somewhere safe to live.

The Protocol Families Actually Use

The protocols that come out of the Trying Low Oxalates community for autism are not radical, but they require patience and careful titration. Dumping in children can be dramatic — increased stimming, regression, rashes, sleep disruption — and signals that you reduced too fast, not that it isn't working.

• Slow oxalate reduction — 25% per month, not all at once.
• Calcium citrate with every meal (child-appropriate dose, often 100-200mg).
• P5P 25-50mg depending on size.
• Biotin 5mg.
• Magnesium glycinate or citrate at bowel tolerance.
• Epsom salt baths 2-3x per week.
• Probiotics with oxalate-degrading strains.
• Bone broth and gelatin for gut barrier repair.
• Remove top oxalate foods — almond flour, spinach, sweet potato, dark chocolate, soy.
• Hydration — gentle, consistent, not forced.

Reported gains: better sleep, calmer behavior, language gains, fewer GI symptoms, less stimming. Not always. Not for everyone. But for enough families that the protocol has earned a place in the toolkit.

Why Mainstream Medicine Won't Touch This

Three reasons. First, there is no patentable drug. A low-oxalate diet and a $10 bottle of P5P don't fund clinical trials. Second, the framework is metabolic and multifactorial, which doesn't fit the single-mechanism-single-drug model academic medicine prefers. Third, autism research funding is dominated by genetics and neurology programs that have explicitly ruled out metabolic and nutritional interventions as "fringe."

The data is sitting there. Konstantynowicz published in 2012. Owens has been organizing the community for two decades. The mechanism is biochemically straightforward. The intervention is cheap and safe. The reason it isn't standard of care is not science. It is economics and inertia.

In the meantime, parents who do their own homework get their kids back. That is its own kind of evidence.

FAQ